Literature DB >> 23871617

MicroRNA associated with atherogenic dyslipidemia in South Asian men.

Elena Flowers1, Komal Singh, César Molina, Ashish Mathur, Bradley E Aouizerat.   

Abstract

Entities:  

Keywords:  Cardiovascular risk; Cholesterol; Lipids; Lipoproteins; MicroRNA; South Asian

Mesh：

Substances：

Year:  2013        PMID： 23871617      PMCID： PMC3809319          DOI： 10.1016/j.ijcard.2013.07.029

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  10 in total

Review 1.  MicroRNA regulation of lipid metabolism.

Authors:  Elena Flowers; Erika Sivarajan Froelicher; Bradley E Aouizerat
Journal:  Metabolism       Date:  2012-05-17       Impact factor: 8.694

2.  Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies.

Authors:  S Yusuf; S Reddy; S Ounpuu; S Anand
Journal:  Circulation       Date:  2001-12-04       Impact factor: 29.690

3.  Differential miRNA expression in omental adipose tissue and in the circulation of obese patients identifies novel metabolic biomarkers.

Authors:  H M Heneghan; N Miller; O J McAnena; T O'Brien; M J Kerin
Journal:  J Clin Endocrinol Metab       Date:  2011-03-02       Impact factor: 5.958

4.  Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE)

Authors:  S S Anand; S Yusuf; V Vuksan; S Devanesen; K K Teo; P A Montague; L Kelemen; C Yi; E Lonn; H Gerstein; R A Hegele; M McQueen
Journal:  Lancet       Date:  2000-07-22       Impact factor: 79.321

5.  Unsaturated fatty acids inhibit the expression of tumor suppressor phosphatase and tensin homolog (PTEN) via microRNA-21 up-regulation in hepatocytes.

Authors:  Manlio Vinciguerra; Antonino Sgroi; Christelle Veyrat-Durebex; Laura Rubbia-Brandt; Leo H Buhler; Michelangelo Foti
Journal:  Hepatology       Date:  2009-04       Impact factor: 17.425

6.  MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation.

Authors:  Ruirui Ji; Yunhui Cheng; Junming Yue; Jian Yang; Xiaojun Liu; He Chen; David B Dean; Chunxiang Zhang
Journal:  Circ Res       Date:  2007-05-03       Impact factor: 17.367

7.  Insulin and HDL-cholesterol metabolism.

Authors:  P Fossati; M Romon-Rousseaux
Journal:  Diabete Metab       Date:  1987-07

8.  MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts.

Authors:  Thomas Thum; Carina Gross; Jan Fiedler; Thomas Fischer; Stephan Kissler; Markus Bussen; Paolo Galuppo; Steffen Just; Wolfgang Rottbauer; Stefan Frantz; Mirco Castoldi; Jürgen Soutschek; Victor Koteliansky; Andreas Rosenwald; M Albert Basson; Jonathan D Licht; John T R Pena; Sara H Rouhanifard; Martina U Muckenthaler; Thomas Tuschl; Gail R Martin; Johann Bauersachs; Stefan Engelhardt
Journal:  Nature       Date:  2008-11-30       Impact factor: 49.962

9.  MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths.

Authors:  Danish Sayed; Shweta Rane; Jacqueline Lypowy; Minzhen He; Ieng-Yi Chen; Himanshu Vashistha; Lin Yan; Ashwani Malhotra; Dorothy Vatner; Maha Abdellatif
Journal:  Mol Biol Cell       Date:  2008-05-28       Impact factor: 4.138

10.  Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.

Authors:  Salim Yusuf; Steven Hawken; Stephanie Ounpuu; Tony Dans; Alvaro Avezum; Fernando Lanas; Matthew McQueen; Andrzej Budaj; Prem Pais; John Varigos; Liu Lisheng
Journal:  Lancet       Date:  2004 Sep 11-17       Impact factor: 79.321
  10 in total
  6 in total

1.  MicroRNA associated with dyslipidemia and coronary disease in humans.

Authors:  Elena Flowers; Bradley E Aouizerat
Journal:  Physiol Genomics       Date:  2013-10-29       Impact factor: 3.107

2.  Circulating microRNA-320a and microRNA-486 predict thiazolidinedione response: Moving towards precision health for diabetes prevention.

Authors:  Elena Flowers; Bradley E Aouizerat; Fahim Abbasi; Cynthia Lamendola; Kaylene M Grove; Yoshimi Fukuoka; Gerald M Reaven
Journal:  Metabolism       Date:  2015-05-28       Impact factor: 8.694

3.  Exosomal MicroRNA Expression Profiling Analysis of the Effects of Lycium Barbarum Polysaccharide on Gestational Diabetes Mellitus Mice.

Authors:  Ya Xiao; Weihao Chen; Ruixue Chen; Anling Luo; Dayi Chen; Qiuer Liang; Tianhao Liu; Xudong Chen; Wei Tan
Journal:  Evid Based Complement Alternat Med       Date:  2020-07-30       Impact factor: 2.629

Review 4.  Premature Coronary Heart Disease in South Asians: Burden and Determinants.

Authors:  Sarah T Ahmed; Hasan Rehman; Julia M Akeroyd; Mahboob Alam; Tina Shah; Ankur Kalra; Salim S Virani
Journal:  Curr Atheroscler Rep       Date:  2018-01-27       Impact factor: 5.113

5.  Circulating micrornas associated with glycemic impairment and progression in Asian Indians.

Authors:  Elena Flowers; Meghana Gadgil; Bradley E Aouizerat; Alka M Kanaya
Journal:  Biomark Res       Date:  2015-10-13

6.  Preliminary evidence supports circulating microRNAs as prognostic biomarkers for type 2 diabetes.

Authors:  E Flowers; A M Kanaya; Y Fukuoka; I E Allen; B Cooper; B E Aouizerat
Journal:  Obes Sci Pract       Date:  2017-10-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.